DOW JONES22,152.00+515.22 2.38%
S&P 5002,610.31+68.84 2.71%
NASDAQ7,762.22+259.84 3.46%

JP Morgan Initiates Coverage On Revolution Medicines with Neutral Rating, Announces $32 Price Target

JP Morgan analyst Eric Joseph initiates coverage on Revolution Medicines (NASDAQ:RVMD) with a Neutral rating and a $32 price target.

Benzinga · 03/09/2020 12:14

JP Morgan analyst Eric Joseph initiates coverage on Revolution Medicines (NASDAQ:RVMD) with a Neutral rating and a $32 price target.